Accent Therapeutics
Translating extraordinary science into life-changing therapeutics for patients living with cancer
- Business Model
- B2B
- Website
- accenttx.com
- Last Round
- Series CJan 2024
- Rounds
- 3
About
Accent Therapeutics pioneers small molecule precision cancer therapies targeting RNA-modifying proteins across multiple cancer types.
Summary
Accent Therapeutics is a Biotech company based in United States. Its most recent funding was a Series C round in Jan 2024. Investors include EcoR1 Capital, Mirae Asset and The Column Group.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...